3-methylcholanthrene has been researched along with oxolinic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horikoshi, J; Kaneko, M | 3 |
3 other study(ies) available for 3-methylcholanthrene and oxolinic acid
| Article | Year |
|---|---|
Reversible suppression by nalidixic acid of anchorage-independent growth of mouse cells transformed by 3-methylcholanthrene or an activated c-Ha-ras gene.
Topics: Animals; Cell Line, Transformed; Clone Cells; Methylcholanthrene; Mice; Mice, Inbred BALB C; Mitosis; Nalidixic Acid; Oncogene Protein p21(ras); Oncogenes; Oxolinic Acid; Pipemidic Acid | 1989 |
Topoisomerase inhibitors suppressed lithocholic acid-induced promotion of transformation in BALB/3T3.
Topics: Animals; Cell Line, Transformed; Cell Transformation, Neoplastic; Fibroblasts; Lithocholic Acid; Methylcholanthrene; Mice; Nalidixic Acid; Oxolinic Acid; Topoisomerase I Inhibitors | 1987 |
Nalidixic acid and oxolinic acid reversibly suppress 3-methylcholanthrene-induced cell transformation of BALB/3T3 mouse cells.
Topics: Animals; Cell Communication; Cell Transformation, Neoplastic; Cells, Cultured; Methylcholanthrene; Mice; Nalidixic Acid; Oxolinic Acid; Tetradecanoylphorbol Acetate; Transcription, Genetic | 1988 |